Final overall survival: Fulvestrant 500 mg vs 250 mg in the randomized confirm trial

  1. Leo, A.D.
  2. Jerusalem, G.
  3. Petruzelka, L.
  4. Torres, R.
  5. Bondarenko, I.N.
  6. Khasanov, R.
  7. Verhoeven, D.
  8. Pedrini, J.L.
  9. Smirnova, I.
  10. Lichinitser, M.R.
  11. Pendergrass, K.
  12. Malorni, L.
  13. Garnett, S.
  14. Rukazenkov, Y.
  15. Martin, M.
Journal:
Journal of the National Cancer Institute

ISSN: 1460-2105,  0027-8874

Year of publication: 2014

Volume: 106

Issue: 1

Type: Article

DOI: 10.1093/JNCI/DJT337 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus